Module 2: Pharmaceutics

What are inactive components of drugs?

Components that are added during manufacturing process and do not increase or affect therapeutic action of the active ingredient

What do inactive ingredients do?

- Solvents dissolve drug substance
- Flavors and sweeteners make product more palatable
- Colorants enhance appeal
- Preservatives prevent microbial growth
- Stabilizers, such as antioxidants and chelating agents, prevent decomposition
- Diluents or fille

What are differences between generic and brand name drugs?

Generic drugs are drugs created to be the same as the brand name drug, must be bioequivalent (within 20% of name brand)
generics are much less expensive d/t competition between companies and no need for ads

disadvantages of generic drugs

may have several manufacturers
may look different
may see differences in amount or rate of dissolution

bioequivalence

same rate and extent of absorption
Acts on same target, ie receptor, as the brand-name
Same amount of active drug is delivered to target site

how long does drug development typically take?

10-15 yrs

5 stages of drug development

1. Discovery and development
2. Preclinical research
3. Clinical research
4. FDA review
5. FDA post-marketing safety monitoring

discovery & development

random screening, molecular designing, investigating drug metabolites, chance discovery --> mechanism of action, pharmacokinetics, potential side effects, toxicity risk

preclinical research

toxicity risk, in vitro studies and animal testing, figure out how to make large quantities, file applications with FDA to test on humans

phases pic

4 phases of clinical trials: who and how long?

phase 1: healthy volunteers, several months
phase 2: larger # with condition, 2 yrs
phase 3: more people with condition, 1-4 yrs
phase 4: post-market safety monitoring with FDA after being approved

clinical trial phase 1: questions

how does drug interact with human body? dose adjustments with humans, acute side effects, how best to admin drug

clinical trial phase 3: questions

most safety data!
(uncommon side effects)

clinical trial phase 2: questions

establish efficacy and side effects, gather safety data

benefits of controlled release, sustained release, and extended release drugs

o Reduced dose frequency compared with conventional dosage forms
o Maintenance of therapeutic effect overnight
o Decreased incidence and intensity of undesired effects through dampening of peaks in drug levels
o Reduction in nontherapeutic blood levels of

drawbacks to CR/SR/ER

o More expensive
o Dose dumping possible
o Patient education: don't break/chew tablets

FDA mission statement

The Food and Drug Administration is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the safety of our nation's food suppl

What is regulated by FDA?

OTC drugs, prescribed drugs
not herbal products or vitamins

Pure Food and Drug Act of 1906

prohibited mislabeling and adulteration of drugs

Opium Exclusion Act of 1909

prohibited importation of opium

Amendment (1912) to the Pure Food and Drug Act

prohibited false or fraudulent advertising claims

Harrison Narcotic Act of 1914

established regulations for use of opium, opiates, and cocaine (marijuana added in 1937)

Food, Drug, and Cosmetic Act of 1938

requires that new drugs must be as pure (but did not require proof of efficacy). Enforcement by FDA.

Durham-Humphrey Act of 1952

Vested in the
FDA
the power to determine which products could be sold without
prescription

Kefauver-Harris Amendments (1962) to the Food, Drug, and Cosmetic Act

Required proof of efficacy as well as safety for new drugs released since 1938; established guidelines for reporting of information about adverse reactions, clinical testing, and advertising of new drugs

Abuse Prevention and Control Act (1970)

schedules and programs to prevent and treat drug addiction

Orphan Drug Amendment of 1983

Provided incentives for development of drugs that treat diseases with fewer than 200,000 patients in the USA

Drug Price Competition and Patent Restoration Act of 1984

Abbreviated new drug applications for generic drugs. Required bioequivalence data. Patent lief extended by amount of time drug delayed by FDA review process. Cannot exceed 5 extra years or extend to more than 14 years post-NDA approval

Prescription Drug User Fee Act (1992, reauthorized 2007, 2012)

manufacturers must pay user fees for certain new drug applications. "Breakthrough" products may receive special category approval after expanded phase 1 trials (2012).

Dietary Supplement Health and Education Act (1994)

Established standards with respect to dietary supplements but prohibited the FDA from applying drug efficacy and safety standards to supplements and botanicals. Required the establishment of specific ingredient and nutrition information labeling that defi

Bioterrorism Act

enhanced controls of dangerous biologic agents and toxins. Seeks to protect safety of food, water, and drug supply

Food and Drug Administration Amendments Act of 2007

Granted FDA greater authority over drug marketing, labeling, and direct-to-consumer advertising; required post-approval studies, established active surveillance systems made clinical trial operations ad results more visible to the public

Biologics Price Competition and Innovation Act of 2009

Authorized the FDA to establish a program of abbreviated pathways for approval of "biosimilar" biologics (generic versions of monoclonal antibodies, etc)

FDA Safety and Innovation Act of 2012

Renewed FDA authorization for accelerated approval of urgently needed drugs; established new accelerated process, "breakthrough therapy," in addition to "priority review," "accelerated approval," and "fast-track" procedures

metered-dose inhalers basics

contains pressurized inactive gas that propels a dose of med in each puff

advantages of MDI inhalers

o Wide range of medication can be delivered
o Relatively low costs
o Portable, multi-dose, quick and easy to use
o Suitable for emergencies
o lower doses d/t extra fine particles

common user errors for MDI

inhaling too fast, failure to tilt head to correct position, failure to empty lungs prior to inhalation, and failure to hold breath following inhalation

limitations to MDI

not suitable for young children (without a spacer), doesn't always have dose counter, needs to be shaken and primed, propellant required

dry-powdered inhalers: basics

breath-activated; don't contain pressurized inactive gas to propel med. Breathe in fairly hard to get powder into your lungs

advantages of DPI

small and portable, breath actuated, less coordination required, short tx time

disadvantages of DPI

moderated to high inspiratory flow required, not suitable for young children, may not be suitable for emergencies, partly sensitive to humidity, need proper dose prep and loading

common errors for DPI

not keeping device in correct position while loading dose, failure to tilt head in correct position, insufficient inspiratory effort, not emptying lungs before inhalation

doses for DPI

either general, single-dose capsule-based, multi-unit, or multiple dose

spacers: basics

holds med like a reservoir when inhaler is pressed. Breathe in, open; breathe out, valve closes.

use of spaers

commonly used in children to reduce need for actuation and breathing coordination
used with pressurized MDIs

what would you instruct a patient about transdermal patches?

o Longer on, longer absorption
o Hydration helps, and TDDS helps hydration (doesn't let sweat out)
o works by passive diffusion, so absorption depends on surface area applied and lipid solubility of drug. absorption increases with abraded skin

benefits of transdermal patches

o Avoids first-pass hepatic metabolism, enzymatic digestion attack, drug hydrolysis and degradation in acid media, drug fluctuations, GI irritation, and disease transmission risks
o Can achieve local and systemic effects
o May help overcome poor patient c

def: pharmaceutics

science of drug delivery and disposition

def: bioavailability

fraction of med that makes it to general circulation

in vitro

in lab

in vivo

in animals

generics must have the same...

active ingredient, intended use, dosage form, strength, route of administration, pharmacodynamics, and stability

form for generic

ANDA: abbreviated new drug application

be aware of generics for...

warfarin, thyroid, digoxin, AEDs